Dosage and administration
Warm solution to body temperature. The usual intravenous dose in cattle is 500 mL per 800 to 1,000 pounds of body weight.
Warm solution to body temperature. The usual intravenous dose in cattle is 500 mL per 800 to 1,000 pounds of body weight.
Store between 15°C - 30°C (59°F - 86°F).
Each 500 mL of sterile aqueous solution contains.
Calcium (as calcium borogluconate, equivalent to calcium gluconate 23.2%) .............. 10.8 g
Potassium (as potassium chloride) ........................................................................ 8.0 g
Phosphorus (as sodium hypophosphite • H2O) .......................................................... 2.5 g
Magnesium (as magnesium borogluconate) ............................................................ 1.6 g
Dextrose • H2O .................................................................................................... 75.0 g
MILLIEQUIVALENTS PER LITER
Cations
Calcium ................ 1,080 mEq/L
Potassium ............... 410 mEq/L
Magnesium ............. 261 mEq/L
Sodium .................. 161 mEq/L
Anions
Borogluconate ....... 1,341 mEq/L
Chloride .................. 410 mEq/L
Hypophosphite ......... 161 mEq/L
For use as an aid in the treatment of hypocalcemia (parturient paresis, milk
fever), hypomagnesemia (grass tetany), and other conditions associated with calcium,
magnesium, phosphorus and potassium deficiencies in cattle.
Do not administer this product to animals showing signs of cardiac
distress.
Administration should be made slowly and with care to avoid adverse
effects such as heart block or shock. Perivascular or subcutaneous deposition of hypertonic
solutions may result in severe inflammation at the injection site.
This product contains no preservatives. Use entire contents when first opened.
Discard any unused solution.
Warm solution to body temperature. The usual
intravenous dose in cattle is 500 mL per 800 to 1,000 pounds of body weight.
Store between 15°C - 30°C (59°F - 86°F).
TAKE TIME OBSERVE LABEL DIRECTIONS
Keep Out of Reach of Children
For Animal Use Only
Federal law restricts this drug to use by or on
the order of a licensed veterinarian.
NDC: 11695-6405-5
FOR TREATMENT OF MILK FEVER IN CATTLE
500 mL (16.90 fl oz)
Questions? (855) 724-3461
Reorder #017734
Manufactured by
Nova-Tech, Inc.
Grand Island, NE 68801
Distributed by:Henry Schein Animal Health
Dublin, OH 43017
www.henryscheinvet.com
Lot No.
Exp. Date
18-805
RMS 92-537
AH-017734-01
Rev: 0118
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Calcium Gluconate Monohydrate | ACTIVE INGREDIENT | CZN0MI5R31 | 1 | |
| Dextrose monohydrate | ACTIVE INGREDIENT | LX22YL083G | 1 | |
| Magnesium Gluconate | ACTIVE INGREDIENT | T42NAD2KHC | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Potassium Chloride | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11695-6406 | 11695-6406-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dextrose monohydrate | LX22YL083G | ACTIB |
| Potassium Chloride | 660YQ98I10 | ACTIM |
| Calcium Gluconate Monohydrate | CZN0MI5R31 | ACTIB |
| Phosphorus | 27YLU75U4W | ACTIB |
| Magnesium Gluconate | T42NAD2KHC | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.